Biotechnology

Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Sep 12, 2024, 16:05 ET Neurocrine Biosciences Provides Update on ERUDITE™ Phase 2 Data for Luvadaxistat in Adults with Cognitive Impairment Associated with Schizophrenia

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its ERUDITE™ Phase 2 clinical study of investigational compound luvadaxistat...

Sep 12, 2024, 13:38 ET ALS Network Announces $100,000 Research Grant Awarded to Amprion, Inc.

The ALS Network, formerly ALS Golden West, has awarded a $100,000 grant through its global research program to Amprion, a global leader advancing...

Sep 12, 2024, 12:04 ET City of Hope and Biopharmaceutical Research Company announce first patient has received BRC-001, a first-in-class cannabinoid therapeutic, in a clinical trial investigating supportive care in breast cancer

City of Hope®, one of the largest cancer research and treatment organizations in the United States, and Biopharmaceutical Research Company (BRC), a...

Sep 12, 2024, 11:21 ET FDA Authorizes First Over-the-Counter Hearing Aid Software

Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended...

Sep 12, 2024, 11:00 ET Zambon Announces Publication of Phase 3 PROMIS I and II Study Results in The Lancet Respiratory Medicine Showing Efficacy Results of CMS I-neb in Patients with Non-Cystic Fibrosis Bronchiectasis Colonized with P. aeruginosa

Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people's health and the quality of patients' lives,...

Sep 12, 2024, 10:16 ET Florida Cancer Specialists & Research Institute Contributing to Transformative Cancer Therapies Worldwide

Cutting-edge clinical research conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) is being shared this week at the European...

Sep 12, 2024, 10:00 ET B.More Collaborator, Dr. Michael Bogenschutz, Awarded NIAAA Grant for Psilocybin in Alcohol Use Disorder Trial at NYU and Silver Hill Hospital

B.More Inc., a 501(c)(3) non-profit, clinical-stage biopharmaceutical company dedicated to the development of psychedelic medicines for substance...

Sep 12, 2024, 10:00 ET Neuspera Medical, Inc. Welcomes Bunty Banerjee as Its First Chief Operating Officer

Neuspera Medical, Inc., a neuromodulation company pioneering the Neuspera Sacral Neuromodulation (SNM) System, announced today that Bunty Banerjee...

Sep 12, 2024, 09:00 ET Equitable Breakthroughs in Medicine Development (EQBMED) to work with Inaugural Sponsor Companies to Drive Greater Diversity in Clinical Trials

Equitable Breakthroughs in Medicine Development (EQBMED) is pleased to announce sponsor companies, Amgen and Merck—known as MSD outside the United...

Sep 12, 2024, 09:00 ET Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform

Cellares, the world's first Integrated Development and Manufacturing Organization (IDMO) and a leader in automated cell therapy manufacturing, and...

Sep 12, 2024, 08:32 ET Inform Solutions Introduces Premium Design and Publishing Services for Biotech and Life Sciences Companies

Inform Solutions, a premier provider of investment-ready brand foundations and strategic communications for innovative startups, is proud to announce ...

Sep 12, 2024, 08:30 ET TCBP Announces First Patient Completed the Full Dose Regimen in ACHIEVE Clinical Trial

TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic...

Sep 12, 2024, 08:10 ET Sobi® and Enable Injections announce agreement to develop and distribute Aspaveli® in combination with enFuse® in Sobi territories

Sobi® (STO: SOBI) and Enable Injections, Inc. (Enable) today announced an international development and distribution agreement across Sobi...

Sep 12, 2024, 08:05 ET Rigel to Present at the 2024 Cantor Global Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...

Sep 12, 2024, 08:00 ET The Kineticos AMR Accelerator Fund I Invests in Orthobond

Kineticos Life Sciences, a life sciences investor focused on companies striving to disrupt how drugs are developed, diseases are diagnosed, and...

Sep 12, 2024, 08:00 ET Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Bright Minds Biosciences announces Phase 2 Clinical trial to evaluate BMB-101 in a group of drug-resistant epilepsy disorders with high unmet needs...

Sep 12, 2024, 08:00 ET Stealth BioTherapeutics Announces Participation at Upcoming Ophthalmology Conferences

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and...

Sep 12, 2024, 08:00 ET BioVaxys to Present at the Life Sciences Investor Forum on September 19th

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") a clinical-stage company developing a portfolio of...

Sep 12, 2024, 08:00 ET Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer

Alchemab Therapeutics (Alchemab), a pharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient...

Sep 12, 2024, 08:00 ET Aurora Biosynthetics Launches to Revolutionize RNA Therapeutics Manufacturing

Aurora Biosynthetics, a pioneering advanced RNA therapeutics manufacturing company, announced its official launch. This heralds a new era in RNA...

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms
& Influencers
icon1
9k+ Digital
Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE